VRS
RCKT icon

Virginia Retirement Systems’s Rocket Pharmaceuticals RCKT Stock Holding History

Virginia Retirement Systems’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,400
Closed -$42.6K – 1029
2025
Q2 		$42.6K Hold
17,400
– – ﹤0.01% 931
2025
Q1 		$116K Buy
+17,400
New +$172K ﹤0.01% 995

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Virginia Retirement Systems's RCKT Position: Q3 2025 in Review

Virginia Retirement Systems sold out of Rocket Pharmaceuticals (RCKT) in Q3 2025, closing a stake of 17,400 shares — an estimated $42.6K sold.

Virginia Retirement Systems first reported a position in RCKT in Q1 2025 and held it in 2 quarters. The position peaked at $116K in Q1 2025. 173 funds tracked by Wall St. Rank hold RCKT as of Q3 2025.

  • Virginia Retirement Systems reported no remaining Rocket Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Virginia Retirement Systems sold 17,400 Rocket Pharmaceuticals shares in Q3 2025, an estimated $42.6K.
  • Virginia Retirement Systems first reported a position in Rocket Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • Virginia Retirement Systems's Rocket Pharmaceuticals position peaked at $116K in Q1 2025.
  • 173 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2025.

Based on Virginia Retirement Systems's 13F filing for Q3 2025, filed 20 Oct 2025.